Titre : Steroid 16-alpha-hydroxylase

Steroid 16-alpha-hydroxylase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Molecular Docking Simulation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Steroid 16-alpha-hydroxylase : Questions médicales les plus fréquentes", "headline": "Steroid 16-alpha-hydroxylase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Steroid 16-alpha-hydroxylase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-11", "dateModified": "2025-04-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Steroid 16-alpha-hydroxylase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Steroid hydroxylases", "url": "https://questionsmedicales.fr/mesh/D013250", "about": { "@type": "MedicalCondition", "name": "Steroid hydroxylases", "code": { "@type": "MedicalCode", "code": "D013250", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.422.220.453.915" } } }, "about": { "@type": "MedicalCondition", "name": "Steroid 16-alpha-hydroxylase", "alternateName": "Steroid 16-alpha-Hydroxylase", "code": { "@type": "MedicalCode", "code": "D039181", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ki-Hwa Kim", "url": "https://questionsmedicales.fr/author/Ki-Hwa%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea." } }, { "@type": "Person", "name": "Tae-Jin Oh", "url": "https://questionsmedicales.fr/author/Tae-Jin%20Oh", "affiliation": { "@type": "Organization", "name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Chang Woo Lee", "url": "https://questionsmedicales.fr/author/Chang%20Woo%20Lee", "affiliation": { "@type": "Organization", "name": "Research Unit of Cryogenic Novel Materials, Korea Polar Research Institute, Incheon 21990, Republic of Korea." } }, { "@type": "Person", "name": "Pradeep Subedi", "url": "https://questionsmedicales.fr/author/Pradeep%20Subedi", "affiliation": { "@type": "Organization", "name": "Department of Life Science and Biochemical Engineering, Sunmoon University, Asan 31460, Republic of Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.", "datePublished": "2022-08-26", "url": "https://questionsmedicales.fr/article/36026508", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0268269" } }, { "@type": "ScholarlyArticle", "name": "Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.", "datePublished": "2024-05-21", "url": "https://questionsmedicales.fr/article/38773273", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-62520-2" } }, { "@type": "ScholarlyArticle", "name": "Exploring the molecular mechanism of ginseng against anthracycline-induced cardiotoxicity based on network pharmacology, molecular docking and molecular dynamics simulation.", "datePublished": "2024-09-06", "url": "https://questionsmedicales.fr/article/39243097", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s41065-024-00334-y" } }, { "@type": "ScholarlyArticle", "name": "Study of the antidiabetic mechanism of berberine compound on FOXO1 transcription factor through molecular docking and molecular dynamics simulations.", "datePublished": "2024-07-09", "url": "https://questionsmedicales.fr/article/38981921", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00894-024-06060-6" } }, { "@type": "ScholarlyArticle", "name": "Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives.", "datePublished": "2023-07-08", "url": "https://questionsmedicales.fr/article/37453331", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.foodchem.2023.136836" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Hémoprotéines", "item": "https://questionsmedicales.fr/mesh/D006420" }, { "@type": "ListItem", "position": 5, "name": "Cytochromes", "item": "https://questionsmedicales.fr/mesh/D003580" }, { "@type": "ListItem", "position": 6, "name": "Cytochrome P-450 enzyme system", "item": "https://questionsmedicales.fr/mesh/D003577" }, { "@type": "ListItem", "position": 7, "name": "Steroid hydroxylases", "item": "https://questionsmedicales.fr/mesh/D013250" }, { "@type": "ListItem", "position": 8, "name": "Steroid 16-alpha-hydroxylase", "item": "https://questionsmedicales.fr/mesh/D039181" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Steroid 16-alpha-hydroxylase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Steroid 16-alpha-hydroxylase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Steroid 16-alpha-hydroxylase", "description": "Comment diagnostiquer une déficience en 16-alpha-hydroxylase ?\nQuels tests génétiques sont utilisés pour cette enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nQuel rôle joue l'imagerie dans le diagnostic ?\nLes tests de fonction hépatique sont-ils pertinents ?", "url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Molecular+Docking+Simulation&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Steroid 16-alpha-hydroxylase", "description": "Quels sont les symptômes d'une surproduction d'androgènes ?\nComment se manifeste une insuffisance en stéroïdes ?\nLes symptômes varient-ils selon le sexe ?\nY a-t-il des symptômes associés à des troubles métaboliques ?\nLes symptômes peuvent-ils apparaître à l'adolescence ?", "url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Molecular+Docking+Simulation&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Steroid 16-alpha-hydroxylase", "description": "Peut-on prévenir les troubles liés à cette enzyme ?\nY a-t-il des tests de dépistage recommandés ?\nComment l'éducation peut-elle aider à la prévention ?\nLes habitudes alimentaires influencent-elles la santé hormonale ?\nLe stress a-t-il un impact sur cette enzyme ?", "url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Molecular+Docking+Simulation&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Steroid 16-alpha-hydroxylase", "description": "Quels traitements sont disponibles pour les déséquilibres hormonaux ?\nLes médicaments peuvent-ils aider à réguler cette enzyme ?\nY a-t-il des traitements non médicamenteux ?\nComment la chirurgie peut-elle être impliquée ?\nLes traitements sont-ils différents pour les hommes et les femmes ?", "url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Molecular+Docking+Simulation&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Steroid 16-alpha-hydroxylase", "description": "Quelles complications peuvent survenir avec un déséquilibre hormonal ?\nLes troubles psychologiques sont-ils liés à cette enzyme ?\nY a-t-il des risques de cancer associés ?\nComment les maladies métaboliques sont-elles liées ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Molecular+Docking+Simulation&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Steroid 16-alpha-hydroxylase", "description": "Quels facteurs de risque sont associés à des troubles hormonaux ?\nL'âge influence-t-il le risque de déséquilibre hormonal ?\nLes médicaments peuvent-ils affecter cette enzyme ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes facteurs environnementaux influencent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D039181?mesh_terms=Molecular+Docking+Simulation&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en 16-alpha-hydroxylase ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins pour mesurer les niveaux d'hormones stéroïdiennes sont effectués." } }, { "@type": "Question", "name": "Quels tests génétiques sont utilisés pour cette enzyme ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses génétiques ciblent les mutations dans le gène CYP3A4." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'hyperandrogénie ou des irrégularités menstruelles peuvent survenir." } }, { "@type": "Question", "name": "Quel rôle joue l'imagerie dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à évaluer les glandes endocrines, mais n'est pas spécifique." } }, { "@type": "Question", "name": "Les tests de fonction hépatique sont-ils pertinents ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, car le foie est crucial pour le métabolisme des stéroïdes et peut indiquer des anomalies." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une surproduction d'androgènes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Acné, hirsutisme, irrégularités menstruelles et infertilité peuvent se manifester." } }, { "@type": "Question", "name": "Comment se manifeste une insuffisance en stéroïdes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, perte de poids, hypotension et dépression peuvent être des signes d'insuffisance." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le sexe ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les hommes et les femmes peuvent présenter des symptômes différents en raison des hormones." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à des troubles métaboliques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme le diabète peuvent être liés à des anomalies hormonales." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils apparaître à l'adolescence ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements hormonaux peuvent se manifester durant la puberté." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés à cette enzyme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance régulière et un mode de vie sain peuvent aider à prévenir certains troubles." } }, { "@type": "Question", "name": "Y a-t-il des tests de dépistage recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests hormonaux réguliers peuvent être recommandés pour les personnes à risque." } }, { "@type": "Question", "name": "Comment l'éducation peut-elle aider à la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sur les symptômes et les risques peut aider à une détection précoce." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles la santé hormonale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut soutenir la santé hormonale et prévenir des déséquilibres." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur cette enzyme ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affecter la production hormonale et aggraver les symptômes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les déséquilibres hormonaux ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies hormonales substitutives peuvent être prescrites pour rétablir l'équilibre." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réguler cette enzyme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains inhibiteurs enzymatiques peuvent être utilisés pour moduler l'activité." } }, { "@type": "Question", "name": "Y a-t-il des traitements non médicamenteux ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des changements de mode de vie, comme l'alimentation et l'exercice, peuvent aider." } }, { "@type": "Question", "name": "Comment la chirurgie peut-elle être impliquée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, une intervention chirurgicale peut être nécessaire pour corriger des anomalies." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les hommes et les femmes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction des besoins hormonaux spécifiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un déséquilibre hormonal ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme l'infertilité, le diabète et des maladies cardiovasculaires peuvent survenir." } }, { "@type": "Question", "name": "Les troubles psychologiques sont-ils liés à cette enzyme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme l'anxiété et la dépression peuvent être exacerbés par des déséquilibres." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre les déséquilibres hormonaux et le cancer hormonal." } }, { "@type": "Question", "name": "Comment les maladies métaboliques sont-elles liées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les déséquilibres hormonaux peuvent contribuer à des maladies métaboliques comme le diabète." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié et précoce." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés à des troubles hormonaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux, l'obésité et le stress sont des facteurs de risque connus." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de déséquilibre hormonal ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout pendant la ménopause chez les femmes." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils affecter cette enzyme ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent interférer avec l'activité de la stéroïde 16-alpha-hydroxylase." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle dans le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certains produits chimiques peut affecter la fonction hormonale." } } ] } ] }

Sources (10000 au total)

Exploring the molecular mechanism of ginseng against anthracycline-induced cardiotoxicity based on network pharmacology, molecular docking and molecular dynamics simulation.

Previous clinical and basic studies have revealed that ginseng might have cardioprotective properties against anthracycline-induced cardiotoxicity (AIC). However, the underlying mechanism of ginseng a... Fourteen drug-disease common targets were identified. Enrichment analysis showed that the AGE-RAGE in diabetic complications, fluid shear stress and atherosclerosis, and TNF signaling pathway were pot... This study suggested that ginseng might exert their protective effects against AIC through the derived effector compounds beta-Sitosterol, Kaempferol and Fumarine by targeting CCNA2, STAT1, and ICAM1,...

Study of the antidiabetic mechanism of berberine compound on FOXO1 transcription factor through molecular docking and molecular dynamics simulations.

Diabetes mellitus (DM) is a metabolic disorder disease that causes hyperglycemia conditions and associated with various chronic complications leading to mortality. Due to high toxicity of conventional... Docking between ligand and FOXO1 receptor was carried out with Autodock4.2. For molecular dynamics simulations, the force fields of DNA.OL15, protein.ff14SB, gaff2, and tip3p were used....

Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives.

During storage and processing, muscle proteins, e.g. myosin and myoglobin, will inevitably undergo degeneration, which is thus accompanied by quality deterioration of muscle foods. Some exogenous addi...

Discovery of Highly Potent CRBN Ligands and Insight into Their Binding Mode through Molecular Docking and Molecular Dynamics Simulations.

Cereblon (CRBN) is a substrate receptor of E3 ubiquitin ligase as well as the target of thalidomide and lenalidomide, plays a vital role in endogenous protein degradation. In this article, two series ...

QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-

Cancer is a serious threat to human life and social development and the use of scientific methods for cancer prevention and control is necessary. In this study, HQSAR, CoMFA, CoMSIA and TopomerCoMFA m...

Molecular modelling on multiepitope-based vaccine against SARS-CoV-2 using immunoinformatics, molecular docking, and molecular dynamics simulation.

The pandemic of COVID-19 caused by SARS-CoV-2 has made a worldwide health emergency. Despite the fact that current vaccines are readily available, several SARSCoV-2 variants affecting the existing vac...

In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin.

Oritavancin is a semi-synthetic lipoglycopeptide antibiotic primarily used to treat serious infections caused by Gram-positive bacteria. The aim of this study was to elucidate possible molecular targe... Computational methods were used in this study which include target prediction, molecular docking, molecular dynamics simulation, pharmacokinetics prediction, and physiological-based pharmacokinetics (... Oritavancin was moderately soluble in water and did not permeate the blood-brain barrier. Seven molecular targets were identified in humans. Molecular docking results showed highest binding affinity o... This comprehensive computational study has provided invaluable insights into the pharmacological profile of Oritavancin, aiding its further development and optimization for clinical use....